FDA shoots down second Novartis petition seeking to halt Entresto generics
Following the FDA’s decision to approve the first Entresto generics in May, the agency has told Novartis that its latest effort …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
